Gennady A. Belitsky

Moscow, MOW 115522, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Journal: Medical sciences (Basel, Switzerland)
Published: December 08, 2025

Epigenetic Activity of Cancer Therapy Drugs Revealed by HeLa TI Cell-Based Assay.

Epigenetic Activity of Cancer Therapy Drugs Revealed by HeLa TI Cell-Based Assay.

Journal: Epigenomes
Published: November 20, 2025

Genetic Heterogeneity of Undifferentiated Pleomorphic Sarcoma: Is There Potential for Targeted Therapy?

Genetic Heterogeneity of Undifferentiated Pleomorphic Sarcoma: Is There Potential for Targeted Therapy?

Journal: Cancers
Published: September 09, 2025

Anticancer Plant Secondary Metabolites Evicting Linker Histone H1.2 from Chromatin Activate Type I Interferon Signaling.

Anticancer Plant Secondary Metabolites Evicting Linker Histone H1.2 from Chromatin Activate Type I Interferon Signaling.

Journal: International journal of molecular sciences
Published: October 18, 2024

Genetic and Molecular Heterogeneity of Synovial Sarcoma and Associated Challenges in Therapy.

Genetic and Molecular Heterogeneity of Synovial Sarcoma and Associated Challenges in Therapy.

Journal: Cells
Published: September 10, 2024

Anticancer Plant Secondary Metabolites Induce Linker Histone Depletion from Chromatin.

Anticancer Plant Secondary Metabolites Induce Linker Histone Depletion from Chromatin.

Journal: Frontiers in bioscience (Landmark edition)
Published: April 24, 2024

Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection.

Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection.

Journal: Cancers
Published: November 14, 2023

Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat.

Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat.

Journal: Biochemistry. Biokhimiia
Published: September 26, 2023

Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins.

Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins.

Journal: International journal of molecular sciences
Published: August 02, 2023

Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy.

Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy.

Journal: International journal of molecular sciences
Published: April 18, 2023

Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo.

Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo.

Journal: Biomedicines
Published: December 01, 2022

Effects of G-Quadruplex-Binding Plant Secondary Metabolites on c-MYC Expression.

Effects of G-Quadruplex-Binding Plant Secondary Metabolites on c-MYC Expression.

Journal: International journal of molecular sciences
Published: August 01, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026